Header Logo

Connection

Michael Kuzniewicz to Jaundice, Neonatal

This is a "connection" page, showing publications Michael Kuzniewicz has written about Jaundice, Neonatal.
Connection Strength

2.128
  1. Predicting the Need for Phototherapy After Discharge: Update for 2022 Phototherapy Guidelines. Pediatrics. 2022 09 01; 150(3).
    View in: PubMed
    Score: 0.858
  2. Association Between Laboratory Calibration of a Serum Bilirubin Assay, Neonatal Bilirubin Levels, and Phototherapy Use. JAMA Pediatr. 2016 06 01; 170(6):557-61.
    View in: PubMed
    Score: 0.557
  3. A Clinical Prediction Rule for Rebound Hyperbilirubinemia Following Inpatient Phototherapy. Pediatrics. 2017 Mar; 139(3).
    View in: PubMed
    Score: 0.146
  4. Phototherapy and Risk of Type 1 Diabetes. Pediatrics. 2016 11; 138(5).
    View in: PubMed
    Score: 0.143
  5. Black race is not protective against hazardous bilirubin levels. J Pediatr. 2013 May; 162(5):1068-9.
    View in: PubMed
    Score: 0.111
  6. Total serum bilirubin exceeding exchange transfusion thresholds in the setting of universal screening. J Pediatr. 2012 May; 160(5):796-800.e1.
    View in: PubMed
    Score: 0.102
  7. Effect of neonatal jaundice and phototherapy on the frequency of first-year outpatient visits. Pediatrics. 2010 Apr; 125(4):729-34.
    View in: PubMed
    Score: 0.090
  8. Numbers needed to treat with phototherapy according to American Academy of Pediatrics guidelines. Pediatrics. 2009 May; 123(5):1352-9.
    View in: PubMed
    Score: 0.085
  9. Risk of Autism Associated With Hyperbilirubinemia and Phototherapy. Pediatrics. 2016 10; 138(4).
    View in: PubMed
    Score: 0.036

© 2024 Kaiser Permanente